The American Physiological Society Press Release

press release logo

APS Contact: Stacy Brooks

Email: sbrooks@the-aps.org

Phone: 301.634.7209

Twitter: @APSPhysiology


E-Cigarette Vapor—Even when Nicotine-Free—Found to Damage Lung Cells

Bethesda, Md. (May 26, 2015)—Electronic cigarette (e-cig) use has now surpassed traditional cigarette use among middle and high school students, according to the Centers for Disease Control and Prevention. This leaves many parents, public health officials and consumers asking whether e-cigarettes are better or worse for lung health than traditional cigarettes. Now, a team of researchers adds its findings to others that suggest nicotine in any form is damaging to lungs. This new research also suggests that non-nicotine-containing e-cig solutions have a damaging effect on lung health, leading researchers to call for more e-cig research.

The loss of integrity in the lung endothelial cells—the cells that make up the lining of the lungs—can contribute to lung injury and inflammation, but it is unknown what component of cigarette smoke causes lung cells to breakdown. Researchers wrote, “We investigated if nicotine, one of the hundreds of molecules present in [cigarette smoke] extracts, is sufficient to alter lung endothelial barrier function by affecting cytoskeletal regulation,” which is the cell’s internal matrix that supports cell shape and function.

The researchers exposed mice and both human and mouse cells to cigarette smoke and e-cigarette solution that either contained nicotine or was nicotine-free. Their findings shed light on how cigarette smoke damages the lungs and point directly to nicotine as the cause. “Nicotine has dose-dependent deleterious pulmonary effects that result in loss of lung endothelial barrier function, acute lung inflammation and decreased lung endothelial cell proliferation,” they wrote. The effects of nicotine were seen both in cigarette smoke and in e-cig solutions that contained nicotine.

Interestingly, nicotine-free e-cig solutions were also found to include lung-harming substances, such as acrolein. This substance, which is present in both e-cig solution and vapor, has been shown to damage the lungs by attacking the molecules that hold endothelial cells together.

“The increased use of inhaled nicotine via e-cigarettes, especially among the youth, prompts increased research into the effects on health. This research reports that components found in commercially available e-cigarette solutions and vapors generated by heating them may cause lung inflammation,” said lead researcher Irina Petrache, PhD. “The effects described characterize short-term effects of e-cig exposures. Whereas studies of long-term effects await further investigations, these results caution that e-cigarette inhalation may be associated with adverse effects on lung health.”

The article “Endothelial disruptive pro-inflammatory effects of nicotine and e-cigarette vapor exposures” is published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology. Read the full article.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact Stacy Brooks at 301-634-7209.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.

 


RelatedItems

E-Cigarette Flavorings, Additives Increase Inflammation and Impair Lung Function

Released October 11, 2018 - Flavoring and additive ingredients in e-cigarettes may increase inflammation and impair lung function, according to new research. The study, published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology, also found that short-term exposure to e-cigarettes was enough to cause lung inflammation similar or worse than that seen in traditional cigarette use. The research was chosen as an APSselect article for October.

Nicotine: The Link Between Cigarette Smoking and Kidney Disease Progression?

Released January 29, 2007 - Cigarette smoke is the most preventable cause of death and chronic disease in the United States. In addition to being a risk factor for cancer, recent epidemiologic studies suggest that cigarette smoke promotes the progression of kidney disease. The mechanisms by which cigarette smoke may accelerate some types of chronic kidney disease are currently unknown. A new study demonstrates for the first time that human mesangial cells (cells in the blood vessels of the kidneys) – are endowed with nicotinic receptors (cells that interact with the nicotine in tobacco) and may play an active role in the development of certain kidney diseases.

Aging + Lung Stiffening = Function Decline

Released March 8, 2018 - New research suggests that certain areas of the lungs are more likely than others to show age-related damage that compromises respiratory function. The paper is published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology.

Stem Cell Transplant Drug May Protect against Smoke-related COPD Symptoms

Released July 3, 2018 - New research suggests that a drug shown to mobilize stem cells in patients with certain cancers that need stem cell transplantation may also protect against cigarette smoke-induced lung injury. The study, published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology, was chosen as an APSselect article for July.

From: 
Email:  
To: 
Email:  
Subject: 
Message:

~/Custom.Templates/PressRelease.aspx